IL223014D0
High concentration antibody formulations
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
101 members in 31 offices
Priority claims6
| Document | Office | Kind | Date |
|---|---|---|---|
| 33498610 | United States of America | P | |
| 2011036062 | United States of America | W | |
| 61334986 | – | – | – |
| PCTUS2011036062 | – | – | – |
| US20100334986P | – | – | – |
| WO2011US36062 | – | – | – |
Members101
| Document | Office | Kind | |
|---|---|---|---|
| CA2798888A1 | Canada | A1 | |
| WO2011143307A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW201144326A | Taiwan Province of China | A | |
| AU2011250920A1 | Australia | A1 | |
| SG185465A1 | Singapore | A1 | |
| IL223014A0 | Israel | A0 | |
| IL223014D0This record | Israel | D0 | |
| CN102946903A | China | A | |
| EP2569010A1 | European Patent Office (EPO) | A1 | |
| CO6640258A2 | Colombia | A2 | |
| EA201291226A1 | Eurasian Patent Organization (EAPO) | A1 | |
| MX2012013268A | Mexico | A | |
| JP2013527176A | Japan | A | |
| US2013202620A1 | United States of America | A1 | |
| KR20130117650A | Republic of Korea | A | |
| CL2012003172A1 | Chile | A1 | |
| CN102946903B | China | B | |
| AU2011250920B2 | Australia | B2 | |
| HN2012002446A | Honduras | A | |
| JP5889877B2 | Japan | B2 | |
| US9352043B2 | United States of America | B2 | |
| JP2016138110A | Japan | A | |
| US2016235849A1 | United States of America | A1 | |
| TW201706304A | Taiwan Province of China | A | |
| BR112012028920A2 | Brazil | A2 | |
| EP2569010B1 | European Patent Office (EPO) | B1 | |
| SG10201701869YA | Singapore | A | |
| PT2569010T | Portugal | T | |
| DK2569010T3 | Denmark | T3 | |
| EA027039B1 | Eurasian Patent Organization (EAPO) | B1 | |
| ES2626033T3 | Spain | T3 | |
| EP3195880A1 | European Patent Office (EPO) | A1 | |
| JP6174176B2 | Japan | B2 | |
| LT2569010T | Lithuania | T | |
| SMT201700252T1 | San Marino | T1 | |
| HRP20170983T1 | Croatia | T1 | |
| PL2569010T3 | Poland | T3 | |
| SI2569010T1 | Slovenia | T1 | |
| HUE033315T2 | Hungary | T2 | |
| EA201692242A1 | Eurasian Patent Organization (EAPO) | A1 | |
| RS56210B1 | Serbia | B1 | |
| JP2017222674A | Japan | A | |
| CY1119069T1 | Cyprus | T1 | |
| ME02819B | Montenegro | B | |
| TWI617570B | Taiwan Province of China | B | |
| KR101861867B1 | Republic of Korea | B1 | |
| KR20180056803A | Republic of Korea | A | |
| US10064946B2 | United States of America | B2 | |
| JP6416336B2 | Japan | B2 | |
| US2019022230A1 | United States of America | A1 | |
| IL223014A | Israel | A | |
| IL223014B | Israel | B | |
| JP2019031515A | Japan | A | |
| IL264636A | Israel | A | |
| KR20190109600A | Republic of Korea | A | |
| KR102026038B1 | Republic of Korea | B1 | |
| CA2798888C | Canada | C | |
| EP3195880B1 | European Patent Office (EPO) | B1 | |
| LT3195880T | Lithuania | T | |
| PT3195880T | Portugal | T | |
| SG10201912670XA | Singapore | A | |
| DK3195880T3 | Denmark | T3 | |
| EP3620175A1 | European Patent Office (EPO) | A1 | |
| SMT202000095T1 | San Marino | T1 | |
| SI3195880T1 | Slovenia | T1 | |
| TWI689517B | Taiwan Province of China | B | |
| HUE047492T2 | Hungary | T2 | |
| RS59993B1 | Serbia | B1 | |
| TW202017941A | Taiwan Province of China | A | |
| HRP20200268T1 | Croatia | T1 | |
| PL3195880T3 | Poland | T3 | |
| ES2773031T3 | Spain | T3 | |
| KR102220879B1 | Republic of Korea | B1 | |
| CY1122669T1 | Cyprus | T1 | |
| BR112012028920B1 | Brazil | B1 | |
| EA037392B1 | Eurasian Patent Organization (EAPO) | B1 | |
| US11040102B2 | United States of America | B2 | |
| US2021275671A1 | United States of America | A1 | |
| ZA201208543B | South Africa | B | |
| JP2022000436A | Japan | A | |
| EA202092884A1 | Eurasian Patent Organization (EAPO) | A1 | |
| TWI759634B | Taiwan Province of China | B | |
| IL264636B | Israel | B | |
| IL295275A | Israel | A | |
| TW202241510A | Taiwan Province of China | A | |
| JP7267707B2 | Japan | B2 | |
| JP2023182702A | Japan | A | |
| EP3620175B1 | European Patent Office (EPO) | B1 | |
| US12178873B2 | United States of America | B2 | |
| EP4483901A2 | European Patent Office (EPO) | A2 | |
| DK3620175T3 | Denmark | T3 | |
| FI3620175T3 | Finland | T3 | |
| PT3620175T | Portugal | T | |
| LT3620175T | Lithuania | T | |
| RS66360B1 | Serbia | B1 | |
| PL3620175T3 | Poland | T3 | |
| SMT202500009T1 | San Marino | T1 | |
| HRP20250025T1 | Croatia | T1 | |
| EP4483901A3 | European Patent Office (EPO) | A3 | |
| ES3008262T3 | Spain | T3 |
Showing 100 of 101
3 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF |
Numbers
- Publication, DOCDB
- 223014
- Publication, EPODOC
- IL223014D
- Application
- 223014
- Application, DOCDB
- 22301412
- Application, EPODOC
- IL20120223014
Titles
- English
- HIGH CONCENTRATION ANTIBODY FORMULATIONS
Classification
- CPC, 17
- A61K47/14
- A61K9/08
- A61K9/0019
- A61K39/395
- A61K39/00
- A61K39/3955
- A61K47/12
- A61K39/39591
- A61K47/26
- A61P19/08
- A61K47/24
- A61K2039/505
- C07K16/22
- C07K2317/76
- A61P1/02
- A61P19/00
- A61P19/10
- IPC, 1
- A61K